270. Chronic recurrent multifocal osteomyelitis Disease details / Clinical trials / Drug dev / DR info
Clinical trial : 1 / Drugs : 10 - (DrugBank : 9) / Drug target genes : 6 - Drug target pathways : 73
Chronic recurrent multifocal osteomyelitis and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
270 | Chronic recurrent multifocal osteomyelitis |
46 | Malignant rheumatoid arthritis |
271 | Ankylosing spondylitis |
107 | Juvenile idiopathic arthritis |
50 | Dermatomyositis |
53 | Sjogren syndrome |
49 | Systemic lupus erythematosus |
13 | Multiple sclerosis/Neuromyelitis optica |
35 | Pemphigus |
40 | Takayasu arteritis |
285 | Fanconi anemia |
41 | Giant cell arteritis |
162 | Pemphigoid |
56 | Behcet disease |
60 | Aplastic anemia |
19 | Lysosomal storage disease |
65 | Primary immunodeficiency |
96 | Crohn disease |
55 | Relapsing polychondritis |
43 | Microscopic polyangiitis |
45 | Eosinophilic granulomatosis with Polyangiitis |
284 | Diamond-Blackfan anemia |
42 | Polyarteritis nodosa |
331 | Idiopathic multicentric castleman disease |
164 | Oculocutaneous albinism |
93 | Primary biliary cholangitis |
11 | Myasthenia gravis |
172 | Hypophosphatasia |
84 | Sarcoidosis |
34 | Neurofibromatosis |
51 | Scleroderma |
97 | Ulcerative colitis |
286 | Hereditary sideroblastic anemia |